Log in
Enquire now
Evotec

Evotec

Contract drug discovery & development offering integrated solutions from Target ID through to Clinic

OverviewStructured DataIssuesContributors

Contents

evotec.com/en
evotec.com
Is a
Venture capital firm
Venture capital firm
Investor
Investor
Company
Company
Organization
Organization

Company attributes

Industry
Chemistry
Chemistry
Enzyme kinetics
Enzyme kinetics
Pharmacokinetics
Pharmacokinetics
‌
Deep Tech
Research and development
Research and development
Biotechnology
Biotechnology
Biology
Biology
Technology
Technology
...
Location
Hamburg
Hamburg
0
Germany
Germany
United Kingdom
United Kingdom
United States
United States
CEO
‌
Werner Lanthaler
0
Pitchbook URL
pitchbook.com/profiles.../12875-50
Legal Name
Evotec AG
Legal classification
Aktiengesellschaft
Aktiengesellschaft
Number of Employees (Ranges)
1,001 – 5,000
Email Address
info@evotec.com0
info@evotec.eu
Number of Employees
4,081
Full Address
Manfred Eigen Campus Essener Bogen 7 22419 Hamburg Germany0
CIK Number
1,412,5580
Place of Incorporation
Germany
Germany
0
Investors
Carb-X
Carb-X
Gilde Healthcare
Gilde Healthcare
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
Novo Holdings A/S
Novo Holdings A/S
Biotechnology Value Fund (BVF Partners)
Biotechnology Value Fund (BVF Partners)
Star Ventures
Star Ventures
Mubadala Development Company
Mubadala Development Company
Founded Date
1993
0
Fax Number
+ 49 (0)40 56081-2220
Total Funding Amount (USD)
74,759,840
Latest Funding Round Date
July 9, 2019
Competitors
KSQ Therapeutics
KSQ Therapeutics
Novavax
Novavax
‌
Faron Pharmaceuticals
Exchange
OTC Markets Group
OTC Markets Group
Latest Funding Type
‌
Venture round
Patents Assigned (Count)
38
Legal Entity Identifier
529900F9KI6OYITO9B12
Country
Germany
Germany
Headquarters
Hamburg
Hamburg

Venture Capital Firm attributes

Invested in
Celmatix
Celmatix
Tubulis Therapeutics
Tubulis Therapeutics
‌
Carrick Therapeutics October 2016 Series A Funding Round
‌
Carrick Therapeutics October 2016 Series A Funding Round
‌
Carrick Therapeutics December 2022 Series C Funding Round
‌
Carrick Therapeutics
Forge Therapeutics
Forge Therapeutics
Immunitas Therapeutics
Immunitas Therapeutics
...

Other attributes

Company Operating Status
Active
Strategic Partnerships
Bioaster
Bioaster
Latest Funding Round Amount (USD)
34,000,000
Partner Organizations
Kazia Therapeutics
Kazia Therapeutics
Previous Name
Evotec AG0
SIC Code
2,8340
Wikidata ID
Q1382629
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Associated Investment Funds

Accelerator Batches

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date

Case study on Evotec

Axial

https://axial.substack.com/p/axial-evotec

Web

References

Find more companies like Evotec

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.